Base Year
Historical Year
Forecast Year
The global hidradenitis suppurativa treatment market attained a value of USD 833.60 million in 2023. The market is expected to grow at a CAGR of 4.20% during the forecast period of 2024-2032, driven by the rising prevalence and the increasing availability of treatment facilities.
Hidradenitis suppurativa (HS) is an autoinflammatory and non-contagious skin condition which targets the hair follicles, leading to recurring abscesses in sweaty areas of the body, which are painful as well. The body parts that can be affected include groin, axillary, perineal, perianal, and inframammary locations. While there is no cure for the condition yet, but the treatment can help relieve the symptoms and prevent further progression of the condition.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Hidradenitis suppurativa (HS), also known as acne inversa, is often diagnosed at a later stage because it is mostly confused with skin infection or severe acne. There is no known diagnostic method to detect this condition, so the patient becomes completely dependent on the dermatologist to diagnose the condition based on the medical history of the patient, symptoms, and the appearance of these lesions. HS also leads to other associated conditions like severe pain, drainage, sensitive skin, odour, and deep scarring. The most common condition where the doctor suggests the possibility of this condition is when the painful lesions are filled with pus and drainage.
It is a sensitive condition which requires proper treatment method customised especially for the patient based on their individual symptoms. The appearance of HS can differ from person to person. HS leads to the formation of skin growths like nodules, abscesses, or sinus tracts.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Skin Condition
Market Breakup by Hurly Stages
Market Breakup by Treatment Method
Market Breakup by End User
Market Breakup by Treatment Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The prevalence of the disease is low, possibly due to the lack of diagnostic facilities for this condition. This can also be attributed to the under-reporting and misdiagnosis of the condition owing to the lack of awareness about the condition. The disease is most likely to occur between the age of puberty to the age of around forty years, especially between the age of 21 to 29 years. Women are more vulnerable to this condition than men, there is a ratio of 3:1 between women and men.
There are no cures for the disease yet, but the treatments can help in reducing inflammation and pain and heal the wounds. The available treatments can help in preventing the progression of the condition.
The treatments currently available in the market include the following:
Skin Care- The first and foremost treatment that the dermatologist opts for the condition in the initial stages is skin care. Regular products available in the market might not help or even aggravate the condition even further. The dermatologist can make a skin care plan customized according to the condition and suggest products that can help in relieving inflammation and pain and these products are also useful in reducing the scarring. The most common addition to the skin care routine is a benzol peroxide facewash, followed by a gentle hydrating moisturizer, and over the top treatment gel. While other treatments might go on for some time, this is something that the patient has to follow throughout the condition to avoid recurrence of the condition.
Drugs or Medications- These drugs can be for be for oral consumption or topical application, depending on the severity of the HS. If the HS is mild and limit to a certain body part, then only topical medication is prescribed. If it is advanced and has spread throughout the body, then a combination of topical and oral medicines is used over a period of time. The most prominent drugs include NSAIDs, antibiotics, oral retinoids, corticosteroid, and hormone therapy, among others. These drugs must be used for the prescribed period of time only and not more due to their high potency.
Surgery- Severe HS is treated with punch debridement, surgical removal, incision and drainage, and issue-sparing excision with electrosurgery.
Other treatment options include in-clinic treatments like corticosteroid injection, laser surgery, botulinum toxin, incision and drainage, wide excision, deroofing, wound and pain care treatments, among others.
The report gives an in-depth analysis of the key players involved in the hidradenitis suppurativa treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Skin Condition |
|
| Breakup by Hurly Stages |
|
| Breakup by Treatment Method |
|
| Breakup by End User |
|
| Breakup by Treatment Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The hidradenitis suppurativa treatment market attained a value of nearly USD 833.60 million in 2023.
The market is projected to grow at a CAGR of 4.20% during the forecast period of 2024-2032.
The growth of the market is driven by factors like rising awareness about the disease.
The rising awareness about the available treatments and the rising accessibility to dermatologists are among the key trends.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Different skin conditions can be categorised into pimples, folliculitis, deep-acne, choroid plexus papilloma/carcinoma, and boils, among others.
The hurly stages of the disease include stage I, II, and III.
Different treatment methods include drugs, surgery, laser treatment, and photodynamic therapy (PDT), among others.
The end-use sectors include hospitals, dermatology clinics, medical research centres, and academic institutes, among others.
The treatment channels in the market include public and private, among others.
The key players in the market include Novartis International AG, InflaRx GmbH, Janssen Biotech, Inc., AbbVie Inc., Celgene Corp., ChemoCentryx Inc., Incyte Corporation, Pfizer Inc., and USB Biopharma.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share